Inferior Vena Cava (IVC) Filter Market, By Product Type (Retrievable IVC Filters and Permanent IVC Filters), By Material (Metal and Non-Metal), By Placement (Suprarenal IVC Filters and Infrarenal IVC Filters), By Application (Deep Vein Thrombosis, Pulmonary Embolism, Trauma and Surgical Procedures, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Aug 2024

Code : CMI7344

Pages :165

Formats :

Excel and PDF

Industry : Medical Devices

Market Concentration and Competitive Landscape

Inferior Vena Cava (IVC) Filter Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising geriatric population

The world population is aging at an unprecedented rate with people generally living longer due to advanced healthcare and lifestyle changes. It is estimated that by 2050, 1 in 6 people globally will be aged 65 years and above. This translates to an enormous expansion of the geriatric demographic worldwide with projections of over 2 billion senior citizens on the planet. As people grow older, their risk of developing chronic health issues rises in tandem. Things like reduced mobility due to arthritis or other age-related impairments curb normal activity levels considerably. The lack of movement coupled with other common comorbidities in the elderly population such as diabetes, heart disease and vascular conditions drastically raises their vulnerability to DVT.

Advanced age itself is considered a significant risk factor because aging diminishes circulatory function and speeds up blood coagulation. It becomes more difficult for the aging body to regulate normal blood flow and clotting tendencies within the leg veins. Therefore, just by virtue of living longer, elderly citizens have a higher probability of experiencing DVT at some point. Managing DVT in the geriatric group is challenging due to coexisting morbidities and healing capacities. Once DVT strikes, it is very common for seniors to suffer recurrences due to persistent pro-clotting tendencies. This makes IVC filters reliably effective alternatives when anti-coagulation alone is insufficient for the older population.

With lifetimes expanding worldwide, there will be increase in proportion of those aged 65 years and above requiring treatment for DVT and related conditions. Catering to the unique healthcare needs of this demographic can boost demand for specialized products like IVC filters. As people celebrate greater longevity, medical device markets must simultaneously address the complex health challenges of advanced age.

Key Players Insights